Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: Clinical and biological results from a prospective multicenter study

Muscle and Nerve

Volumn 43, Issue 2, 2011, Pages 189-195

  Chiò, Adriano ^a   Mora, Gabriele ^b   La Bella, Vincenzo ^c   Caponnetto, Claudia ^d   Mancardi, Gianluigi ^d   Sabatelli, Mario ^e   Siciliano, Gabriele ^f   Silani, Vincenzo ^g   Corbo, Massimo ^h   Moglia, Cristina ^a   Calvo, Andrea ^a   Mutani, Roberto ^a   Rutella, Sergio ⁱ   Gualandi, Francesca ^j   Melazzini, Mario ^b,h   Scimè, Rosanna ^k   Petrini, Mario ^f   Bondesan, Paola ^l   Garbelli, Silvia ^b   Mantovani, Stefania ^b   Bendotti, Caterina ^m   Tarella, Corrado ⁿ   Ghiglione, Paolo ^o   Omedé, Paola ^o   Ulla, Marco ^o   Mascolo, Maria ^o   Carlesi, Cecilia ^o   Tonali, Pietro Attilio ^o   Conte, Amelia ^o   Luigetti, Marco ^o   Alimonti, Dario ^o   Onida, Francesco ^o   Bossolasco, Patrizia ^o   Deliliers, Giorgio Lambertenghi ^o   Valentino, Francesca ^o   more..

^a Centro Per la Sclerosi Laterale Amiotrofica   (Italy)

^b IRCCS   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e Neurologia   (Italy)

^f UNIVERSITY OF PISA   (Italy)

^g UNIVERSITY OF MILAN   (Italy)

^h NEuroMuscular Omnicenter (NEMO)   (Italy)

ⁱ CATHOLIC UNIVERSITY   (Italy)

^j UNIVERSITY OF GENOA   (Italy)

^k VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^l AOU San Giovanni Battista   (Italy)

^m MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

ⁿ MAURIZIANO HOSPITAL   (Italy)

^o Istituto di Ricerche Farmacologiche Mario Negri ^*

more..

Author keywords

Amyotrophic lateral sclerosis; Clinical trial; Granulocyte colony stimulating factor; Hematopoietic stem cells; Neuroinflammation

Indexed keywords

CHEMOKINE; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 17; MANNITOL; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHENIA; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DISEASE COURSE; DRUG SAFETY; FEMALE; FLU LIKE SYNDROME; FORCED VITAL CAPACITY; HUMAN; HYPERPROLACTINEMIA; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CYTOKINES; DISABILITY EVALUATION; FEMALE; FOLLOW-UP STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 78751665486     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21851     Document Type: Article

References (38)

1. Miller RG, Mitchell JD, Lyon M, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2007;1:CD001447.
2. Vora N, Jovin T, Kondziolka D. Cell transplantation for ischemic stroke. Neurodegen Dis 2006;3:101-105.
3. Newman MB, Bakay RA. Therapeutic potentials of human embryonic stem cells in Parkinson's disease. Neurotherapeutics 2008;5:237-251. (Pubitemid 351446218)
4. Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, et al. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 2006;103:16021-16026. (Pubitemid 44657585)
5. Riley J, Sweeney W, Boulis N. Shifting the balance: cell-based therapeutics as modifiers of the amyotrophic lateral sclerosis-specific neuronal microenvironment. Neurosurg Focus 2008;24:E10.
6. Einstein O, Ben-Hur T. The changing face of neural stem cell therapy in neurologic diseases. Arch Neurol 2008;65:452-456. (Pubitemid 351549952)
7. Corti S, Locatelli F, Donaoni C, Guglieri M, Papadimitriou D, Strazzer S, et al. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A mice and contribute to the CNS, heart and skeletal muscle tissues. Brain 2004;127:2518-2532.
8. Nervi B, Link DC, DiPersio JF. Cytokines and hematopoietic stem cell mobilization. J Cell Biochem 2006;99:690-705. (Pubitemid 44521989)
9. Solaroglu I, Jadhav V, Zhang JH. Neuroprotective effect of granulocyte-colony stimulating factor. Frontiers Biosci 2007;12:712-724. (Pubitemid 46852816)
10. Schäbitz WR, Schneider A. New targets for established proteins: exploring G-CSF for the treatment of stroke. Trends Pharmacol Sci 2007;28:157-161. (Pubitemid 46483721)
11. Six I, Gasan G, Mura E, Bordet R. Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia. Eur J Pharmacol 2003;458:327-328. (Pubitemid 36009473)
12. Hennemann B, Ickenstein G, Sauerbruch S, Luecke K, Haas S, Horn M, et al. Mobilization of CD34+ hematopoietic cells, colony-forming cells and long-term culture-initiating cells into the peripheral blood of patients with an acute cerebral ischemic insult. Cytotherapy 2008;10:303-311.
13. Tanaka M, Kikuchi H, Ishizu T, Minohara M, Osoegawa M, Motomura K, et al. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2006;65:816-825.
14. Pitzer C, Krüger C, Plaas C, Kirsch F, Dittgen T, Müller R, et al. Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis. Brain 2008;131:3335-3347.
15. Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-299.
16. Cohen SR, Mount BM, Strobel MG, Bui FI. The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced diseases. A preliminary study of validity and acceptability. Pall Med 1995;9:207-219.
17. Armon C, Graves MC, Moses D, Forte DK, Sepulveda L, Darby SM, et al. Linear estimates of disease progression predict survival in patients with amyotrophic lateral sclerosis. Muscle Nerve 2000;23:874-882.
18. Tarella C, Rutella S, Gualandi F, Melazzini M, Scimé R, Petrini M, et al. Consistent bone marrow-derived cell mobilization following repeated short courses of G-CSF in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial. Cytotherapy 2010;12:50-59.
19. Del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis. A population - based study. Neurology 2003;60:813-819.
20. Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 2009;10:310-323.
21. Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 2006;66:265-267.
22. Moore DH Jr, Miller RG. Improving efficiency of ALS clinical trials using lead-in designs. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5(suppl 1):57-60.
23. Cashman N, Tan LY, Krieger C, Mädler B, Mackay A, Mackenzie I, et al. Pilot study of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (ALS). Muscle Nerve 2008;37:620-625.
24. Zhang Y, Wang L, Fu Y, Song H, Zhao H, Deng M, et al. Preliminary investigation of effect of granulocyte colony stimulating factor on amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2008;10:430-431.
25. Nefussy B, Artamonov I, Deutsch V, Naparstek E, Nagler A, Drory V. Recombinant human granulocyte-colony stimulating factor administration for treating amyotrophic lateral sclerosis: a pilot study. Amyotroph Lateral Scler 2010;11:187-193.
26. Baron P, Bussini S, Cardin V, Corbo M, Conti G, Galimberti D, et al. Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis. Muscle Nerve 2005;32:541-544.
27. Henkel JS, Engelhardt JI, Siklós L, Simpson EP, Kim SH, Pan T, et al. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 2004;55:221-235.
28. Kolls JK, Lindén A. Interleukin-17 family members and inflammation. Immunity 2004;21:467-476.
29. Wang YH, Liu YJ. The IL-17 cytokine family and their role in allergic inflammation. Curr Opin Immunol 2008;20:697-702.
30. Ivanov II, Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008;4:337-49.
31. Kramer JM, Gaffen SL. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. J Periodontol 2007;78:1083-1093.
32. Pongcharoen S, Ritvirool PN, Sanguansermsri D, Chanchan P, Jienmongkol P, Butkhamchot P, et al. Reduced interleukin-17 expression of Burkholderia pseudomallei-infected peripheral blood mononuclear cells of diabetic patients. Asian Pac J Allergy Immunol 2008;26:63-69.
33. Suryani S, Sutton I. An interferon-gamma-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis. J Neuroimmunol 2007;183:96-103.
34. Li GZ, Zhong D, Yang LM, Sun B, Zhong ZH, Yin YH, et al. Expression of interleukin-17 in ischemic brain tissue. Scand J Immunol 2005;62:481-486.
35. Kawanokuchi J, Shimizu K, Nitta A, Yamada K, Mizuno T, Takeuchi H, et al. Production and functions of IL-17 in microglia. J Neuroimmunol 2008;194:54-61.
36. Meeuwsen S, Persoon-Deen C, Bsibsi M, Bajramovic JJ, Ravid R, De Bolle L, et al. Modulation of the cytokine network in human adult astrocytes by human herpesvirus-6A. J Neuroimmunol 2005;164:37-47.
37. Engelhardt JI, Tajti J, Appel SH. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch Neurol 1993;50:30-36. (Pubitemid 23019197)
38. Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 1992;140:691-707.